BGM Group (NASDAQ:BGM) Shares Gap Down – Time to Sell?

Shares of BGM Group Ltd. (NASDAQ:BGMGet Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $9.57, but opened at $9.02. BGM Group shares last traded at $9.49, with a volume of 1,261 shares.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d)” rating on shares of BGM Group in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, BGM Group currently has an average rating of “Sell”.

Read Our Latest Research Report on BGM

BGM Group Stock Down 1.0%

The stock has a 50 day moving average price of $9.26 and a two-hundred day moving average price of $10.23.

Hedge Funds Weigh In On BGM Group

A hedge fund recently bought a new stake in BGM Group stock. Geode Capital Management LLC acquired a new position in shares of BGM Group Ltd. (NASDAQ:BGMFree Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 38,913 shares of the company’s stock, valued at approximately $412,000.

BGM Group Company Profile

(Get Free Report)

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.

Read More

Receive News & Ratings for BGM Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BGM Group and related companies with MarketBeat.com's FREE daily email newsletter.